Since 2022, India has a scientifically proven, indigenous Lumpy Skin Disease-specific vaccine readily available but there has ...

In July 2025, Bristol-Myers Squibb announced a study is to assess the safety and efficacy of nivolumab combined with ...

意大利罗马Agostino Gemelli综合医院妇科肿瘤科Vanda ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

It has recently been observed that bipolar switching between accumulation and inversion can result in an unexpected threshold voltage drift in SiC MOSFETs. This phenomenon has been termed gate ...

Discover the latest breakthroughs in oncology, including pivotal FDA decisions, promising therapies, and new treatment options for multiple myeloma and ovarian cancer.

PDF for Biology from the official Rajasthan Board website. Access chapter-wise details for Biology with the link to download ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug ...

The company, which spun out of a Korean institute, said its test has been listed at 10 leading hospitals and academic centers.

PCAF (p300-associated factor), a major histone acetyltransferase, is involved in many metabolic and pathogenic diseases. Here, we reveal a novel function of PCAF in homologous recombination repair (HR ...